QUALCOMM INC/DE, 10-Q filed on 4/30/2025
Quarterly Report
v3.25.1
Cover Page - shares
shares in Millions
6 Months Ended
Mar. 30, 2025
Apr. 28, 2025
Cover [Abstract]    
Entity Registrant Name QUALCOMM INC/DE  
Entity Central Index Key 0000804328  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Current Fiscal Year End Date --09-28  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 30, 2025  
Document Transition Report false  
Entity File Number 0-19528  
Entity Registrant State of Incorporation DE  
Entity Employer ID 95-3685934  
Entity Address 5775 Morehouse Dr.  
Entity City San Diego  
Entity State CA  
Entity Zip Code 92121-1714  
City Area Code (858)  
Entity Phone Number 587-1121  
Title of 12(b) Security Common Stock, $0.0001 par value  
Trading Symbol QCOM  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   1,098
v3.25.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Millions, $ in Millions
Mar. 30, 2025
Sep. 29, 2024
Current assets:    
Cash and cash equivalents $ 7,203 $ 7,849
Marketable securities 6,643 5,451
Accounts receivable, net 3,699 3,929
Inventories 6,196 6,423
Other current assets 2,339 1,579
Total current assets 26,080 25,231
Deferred tax assets 5,750 5,162
Property, plant and equipment, net 4,410 4,665
Goodwill 10,948 10,799
Other intangible assets, net 1,183 1,244
Other assets 7,001 8,053
Total assets 55,372 55,154
Current liabilities:    
Trade accounts payable 2,479 2,584
Payroll and other benefits related liabilities 1,248 1,834
Unearned revenues 232 297
Short-term debt 1,365 1,364
Other current liabilities 4,220 4,425
Total current liabilities 9,544 10,504
Unearned revenues 82 88
Long-term debt 13,258 13,270
Other liabilities 4,760 5,018
Total liabilities 27,644 28,880
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding $ 0 $ 0
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 8 8
Preferred stock, shares outstanding 0 0
Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,100 and 1,113 shares issued and outstanding, respectively $ 0 $ 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 6,000 6,000
Common stock, shares, issued 1,100 1,113
Common stock, shares, outstanding 1,100 1,113
Retained earnings $ 27,333 $ 25,687
Accumulated other comprehensive income 395 587
Total stockholders’ equity 27,728 26,274
Total liabilities and stockholders’ equity $ 55,372 $ 55,154
v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Mar. 30, 2025
Mar. 24, 2024
Mar. 30, 2025
Mar. 24, 2024
Revenues:        
Equipment and services $ 9,359 $ 7,950 $ 19,301 $ 16,266
Licensing 1,620 1,439 3,348 3,059
Total revenues 10,979 9,389 22,649 19,325
Costs and expenses:        
Cost of revenues 4,937 4,106 10,098 8,418
Research and development 2,216 2,236 4,446 4,332
Selling, general and administrative 706 707 1,430 1,335
Other 0 0 0 (28)
Total costs and expenses 7,859 7,049 15,974 14,057
Operating income 3,120 2,340 6,675 5,268
Interest expense (163) (172) (326) (350)
Investment and other income, net 148 330 391 542
Income from continuing operations before income taxes 3,105 2,498 6,740 5,460
Income tax expense (293) (223) (748) (373)
Income from continuing operations 2,812 2,275 5,992 5,087
Discontinued operations, net of income taxes 0 51 0 6
Net income $ 2,812 $ 2,326 $ 5,992 $ 5,093
Basic earnings per share, Continuing operations $ 2.55 $ 2.03 $ 5.41 $ 4.55
Basic loss per share, Discontinued operations 0 0.05 0 0.01
Basic earnings per share 2.55 2.08 5.41 4.56
Diluted earnings per share, Continuing operations 2.52 2.02 5.36 4.50
Diluted loss per share, Discontinued operations 0 0.04 0 0.01
Diluted earnings per share $ 2.52 $ 2.06 $ 5.36 $ 4.51
Shares used in per share calculations:        
Basic 1,104 1,117 1,107 1,116
Diluted 1,115 1,130 1,118 1,129
v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 30, 2025
Mar. 24, 2024
Mar. 30, 2025
Mar. 24, 2024
Statement of Comprehensive Income [Abstract]        
Net income $ 2,812 $ 2,326 $ 5,992 $ 5,093
Other comprehensive income, net of income taxes:        
Foreign currency translation gains (losses) 82 (62) (134) 21
Net unrealized gains (losses) on available-for-sale debt securities 16 6 (22) 38
Net unrealized gains (losses) on derivative instruments 23 (13) (36) 4
Other losses 0 (1) 0 0
Other reclassifications included in net income 1 15 0 17
Total other comprehensive income (loss) 122 (55) (192) 80
Comprehensive income $ 2,934 $ 2,271 $ 5,800 $ 5,173
v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Mar. 30, 2025
Mar. 24, 2024
Operating Activities:    
Net income from continuing operations $ 5,992 $ 5,087
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 833 848
Income tax provision less than income tax payments (899) (1,764)
Share-based compensation expense 1,461 1,307
Net gains on marketable securities and other investments (9) (273)
Impairment losses on other investments 41 62
Other items (69) (30)
Changes in assets and liabilities:    
Accounts receivable, net 227 92
Inventories 202 328
Other assets 299 221
Trade accounts payable (97) 420
Payroll, benefits and other liabilities (773) 286
Unearned revenues (67) 10
Net cash used by operating activities from discontinued operations 0 (91)
Net cash provided by operating activities 7,141 6,503
Investing Activities:    
Capital expenditures (491) (398)
Purchases of debt and equity marketable securities (3,326) (2,842)
Proceeds from sales and maturities of debt and equity marketable securities 2,155 1,178
Acquisitions and other investments, net of cash acquired (341) (165)
Proceeds from other investments 41 62
Other items 2 (30)
Net cash used by investing activities (1,960) (2,195)
Financing Activities:    
Proceeds from short-term debt 500 799
Repayment of short-term debt (500) (799)
Proceeds from issuance of common stock 201 195
Repurchases and retirements of common stock (3,498) (1,515)
Dividends paid (1,880) (1,790)
Payments of tax withholdings related to vesting of share-based awards (609) (515)
Other items (3) 4
Net cash used by financing activities (5,789) (3,621)
Effect of exchange rate changes on cash and cash equivalents (38) 5
Net (decrease) increase in total cash and cash equivalents (646) 692
Total cash and cash equivalents at beginning of period (including $77 classified as held for sale at September 24, 2023) 7,849 8,527
Total cash and cash equivalents at end of period $ 7,203 9,219
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents, Beginning of Period   $ 77
v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common stock and paid-in capital
Retained earnings
Accumulated other comprehensive income
Balance at beginning of period at Sep. 24, 2023 $ 21,581 $ 490 $ 20,733 $ 358
Common stock issued under employee benefit plans   195    
Repurchases and retirements of common stock   (1,504) (11)  
Share-based compensation   1,377    
Tax withholdings related to vesting of share-based payments   (515)    
Common stock issued in acquisition   23    
Net income     5,093  
Dividends     (1,850)  
Other comprehensive income (loss)       80
Balance at end of period at Mar. 24, 2024 $ 24,469 66 23,965 438
Dividends per share announced $ 1.60      
Balance at beginning of period at Dec. 24, 2023 $ 23,058 0 22,565 493
Common stock issued under employee benefit plans   193    
Repurchases and retirements of common stock   (731) 0  
Share-based compensation   748    
Tax withholdings related to vesting of share-based payments   (144)    
Common stock issued in acquisition   0    
Net income     2,326  
Dividends     (926)  
Other comprehensive income (loss)       (55)
Balance at end of period at Mar. 24, 2024 $ 24,469 66 23,965 438
Dividends per share announced $ 0.80      
Balance at beginning of period at Sep. 29, 2024 $ 26,274 0 25,687 587
Common stock issued under employee benefit plans   201    
Repurchases and retirements of common stock   (1,108) (2,406)  
Share-based compensation   1,516    
Tax withholdings related to vesting of share-based payments   (609)    
Common stock issued in acquisition   0    
Net income     5,992  
Dividends     (1,940)  
Other comprehensive income (loss)       (192)
Balance at end of period at Mar. 30, 2025 $ 27,728 0 27,333 395
Dividends per share announced $ 1.70      
Balance at beginning of period at Dec. 29, 2024 $ 26,880 0 26,607 273
Common stock issued under employee benefit plans   200    
Repurchases and retirements of common stock   (632) (1,120)  
Share-based compensation   726    
Tax withholdings related to vesting of share-based payments   (294)    
Common stock issued in acquisition   0    
Net income     2,812  
Dividends     (966)  
Other comprehensive income (loss)       122
Balance at end of period at Mar. 30, 2025 $ 27,728 $ 0 $ 27,333 $ 395
Dividends per share announced $ 0.85      
v3.25.1
Basis of Presentation and Significant Accounting Policies Update
6 Months Ended
Mar. 30, 2025
Basis of Presentation [Abstract]  
Basis of Presentation and Significant Accounting Policies Update
Note 1. Basis of Presentation and Significant Accounting Policies Update
Financial Statement Preparation. These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information and the instructions to Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, the interim financial information includes all normal recurring adjustments necessary for a fair statement of the results for the interim periods. These condensed consolidated financial statements are unaudited and should be read in conjunction with our Annual Report on Form 10-K for our fiscal year ended September 29, 2024. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year.
We operate and report using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three and six months ended March 30, 2025 and March 24, 2024 included 13 weeks and 26 weeks, respectively. Our fiscal year for 2025 will include 52 weeks.
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation.
Recent Accounting Pronouncements.
Segment Reporting Disclosures: In November 2023, the Financial Accounting Standards Board (FASB) issued new requirements to disclose certain incremental segment information on an annual and interim basis, including (among other items) additional disclosure about significant segment expenses. We will adopt the new requirements for our annual periods starting in fiscal 2025 (and interim periods thereafter) on a retrospective basis.
Income Tax Disclosures: In December 2023, the FASB issued new requirements to disclose annually certain additional detailed income tax information related to the effective tax rate reconciliation and income taxes paid, among other items. We will adopt the new requirements starting in fiscal 2026 on a retrospective basis.
Income Statement - Expense Disaggregation Disclosures: In November 2024, the FASB issued new requirements to disclose certain additional expense information on an annual and interim basis, including (among other items) the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization included within each income statement expense caption, as applicable. We will adopt the new requirements for our annual periods starting in fiscal 2028 (and interim periods thereafter) on a prospective basis.
v3.25.1
Composition of Certain Financial Statement Items
6 Months Ended
Mar. 30, 2025
Condensed Financial Information Disclosure [Abstract]  
Composition of Certain Financial Statement Items
Note 2. Composition of Certain Financial Statement Items
Inventories (in millions)
March 30,
2025
September 29,
2024
Raw materials$298 $340 
Work-in-process3,750 3,497 
Finished goods2,148 2,586 
$6,196 $6,423 
We have multi-year capacity purchase commitments with certain suppliers of our integrated circuit products. Total advance payments related to multi-year capacity purchase commitments recorded on our condensed consolidated balance sheets at March 30, 2025 and September 29, 2024 were $2.7 billion and $3.0 billion, respectively, of which $1.6 billion and $765 million were recorded in other current assets, respectively, and $1.1 billion and $2.2 billion were recorded in other assets, respectively.
Revenues. We disaggregate our revenues by segment (Note 6), by products and services (as presented on our condensed consolidated statements of operations), and for our QCT (Qualcomm CDMA Technologies) segment, by revenue stream, which is based on the industry and application in which our products are sold (as presented below). In certain cases, the determination of QCT revenues by industry and application requires the use of certain assumptions. Substantially all of QCT’s revenues consist of equipment revenues that are recognized at a point in time, and substantially all of QTL’s (Qualcomm Technology Licensing) revenues represent licensing revenues that are recognized over time and are principally from royalties generated through our licensees’ sales of mobile handsets.
QCT revenue streams were as follows (in millions):
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Handsets (1)$6,929 $6,180 $14,503 $12,867 
Automotive (2)959 603 1,920 1,201 
IoT (internet of things) (3)
1,581 1,243 3,130 2,381 
Total QCT revenues$9,469 $8,026 $19,553 $16,449 
(1) Includes revenues from products sold for use in mobile handsets.
(2) Includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and advanced driver assistance systems (ADAS) and automated driving (AD).
(3) Primarily includes products sold for use in the following industries and applications: consumer (including personal computers (PCs), tablets, voice and music and extended reality (XR)), edge networking (including mobile broadband and wireless access points) and industrial (including handhelds, retail, tracking and logistics and utilities).
Revenues recognized from performance obligations satisfied (or partially satisfied) in previous periods generally include certain sales-based royalty revenues related to system software, certain amounts related to customer incentives and licensing revenues recognized related to devices sold in prior periods (including revenues resulting from certain settlements and adjustments to prior period royalty estimates, which include the impact of the reporting by our licensees of actual royalties due) and were as follows (in millions):
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Revenues recognized from previously satisfied performance obligations$285 $55 $526 $206 
Remaining performance obligations, which are primarily included in unearned revenues (as presented on our condensed consolidated balance sheets), represent the aggregate amount of the transaction price of certain customer contracts yet to be recognized as revenues as of the end of the reporting period and exclude revenues related to (a) contracts that have an original expected duration of one year or less and (b) sales-based royalties (i.e., future royalty revenues) pursuant to our license agreements. Our patent license agreements with key OEMs are generally long-term, with remaining terms expiring between fiscal 2027 and 2031.
Concentrations. A significant portion of our revenues are concentrated with a small number of customers/licensees of our QCT and QTL segments. The comparability of customer/licensee concentrations for the periods presented are impacted by the timing of customer/licensee device launches and/or innovation cycles and other seasonal trends, among other fluctuations in demand. Revenues from each customer/licensee that were 10% or greater of total revenues were as follows:
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Customer/licensee (x)
27 %24 %21 %21 %
Customer/licensee (y)
18 19 21 22 
Customer/licensee (z)10 14 12 14 
Investment and Other Income, Net (in millions)
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Interest and dividend income$167 $160 $336 $312 
Net gains (losses) on marketable securities
18 (3)37 
Net (losses) gains on other investments
(5)155 26 159 
Net (losses) gains on deferred compensation plan assets
(34)62 (20)126 
Impairment losses on other investments(16)(50)(41)(62)
Other18 53 (1)
$148 $330 $391 $542 
Discontinued Operations. On June 1, 2023, SSW Partners completed the sale of Veoneer’s Active Safety business to Magna International Inc. for net cash proceeds of $1.5 billion. On March 1, 2024, SSW Partners completed the sale of Veoneer’s Restraint Control Systems business (collectively with the Active Safety business, the Non-Arriver businesses) to American Industrial Partners Capital Fund VII. Through the date of disposition by SSW Partners, the results of operations and cash flows of Veoneer’s Non-Arriver businesses are presented as discontinued operations. Cash flows from investing and financing activities from discontinued operations reported for the periods presented were not material.
v3.25.1
Income Taxes
6 Months Ended
Mar. 30, 2025
Income Tax Disclosure [Abstract]  
Income Taxes
Note 3. Income Taxes
We estimate our annual effective income tax rate to be 11% for fiscal 2025, which is lower than the U.S. federal statutory rate, primarily due to a significant portion of our income qualifying for preferential treatment as foreign-derived intangible income (FDII) at a 13% effective tax rate, which includes certain additional benefits from the requirement to capitalize research and development expenditures for federal income tax purposes (that are expected to continue to decline over time as capitalized research and development expenditures continue to amortize) and a benefit from our federal research and development tax credit. Our effective tax rate of 9% for the second quarter of fiscal 2025 was lower than our estimated annual effective tax rate, primarily due to net discrete tax benefits realized in the second quarter of fiscal 2025.
v3.25.1
Capital Stock
6 Months Ended
Mar. 30, 2025
Equity, Attributable to Parent [Abstract]  
Capital Stock
Note 4. Capital Stock
Stock Repurchase Program. During the first quarter of fiscal 2025, we utilized the remaining repurchase authority under the $10.0 billion stock repurchase program announced on October 12, 2021 and we began repurchases under the $15.0 billion stock repurchase program announced on November 6, 2024, which has no expiration date. At March 30, 2025, $12.5 billion remained authorized for repurchase under our stock repurchase program.
Shares Outstanding. Shares of common stock outstanding at March 30, 2025 were as follows (in millions):
Balance at September 29, 2024
1,113 
Issued
Repurchased(22)
Balance at March 30, 2025
1,100 
Dividends. On March 18, 2025, we announced an increase in our quarterly dividend per share of common stock from $0.85 to $0.89, which is effective for dividends payable after March 27, 2025. On April 18, 2025, we announced a cash dividend of $0.89 per share on our common stock, payable on June 26, 2025 to stockholders of record as of the close of business on June 5, 2025.
Earnings Per Common Share. Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share is computed by dividing net income by the combination of the weighted-average number of common shares outstanding and the weighted-average number of dilutive common share equivalents, comprised of shares issuable under our share-based compensation plans, during the reporting period, using the treasury stock method. The following table provides information about the diluted earnings per share calculation (in millions):
 Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Dilutive common share equivalents included in diluted shares10 13 11 12 
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period— 
v3.25.1
Commitments and Contingencies
6 Months Ended
Mar. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 5. Commitments and Contingencies
Legal and Regulatory Proceedings.
Consumer Class Action Lawsuits: Beginning in January 2017, a number of consumer class action complaints were filed against us in the United States District Courts for the Southern and Northern Districts of California, each on behalf of a putative class of purchasers of cellular phones and other cellular devices. The cases filed in the Southern District of California were subsequently transferred to the Northern District of California. On July 11, 2017, the plaintiffs filed a consolidated amended complaint alleging that we violated California and federal antitrust and unfair competition laws by, among other things, refusing to license standard-essential patents to our competitors, conditioning the supply of certain of our baseband chipsets on the purchaser first agreeing to license our entire patent portfolio, entering into exclusive deals with companies, including Apple Inc., and charging unreasonably high royalties that do not comply with our commitments to standard setting organizations. The complaint sought unspecified damages and disgorgement and/or restitution, as well as an order that we be enjoined from further unlawful conduct. On September 27, 2018, the court certified the class. We appealed the court’s class certification order to the United States Court of Appeals for the Ninth Circuit (Ninth Circuit). On September 29, 2021, the Ninth Circuit vacated the class certification order, ruling that the district court had failed to correctly assess the propriety of applying California law to a nationwide class, and remanded the case to the district court. On June 10, 2022, the plaintiffs filed an amended complaint, limiting the proposed class to California residents rather than a nationwide class. We filed a motion to dismiss the amended complaint, and on January 6, 2023, the court issued an order granting in part and denying in part our motion to dismiss. We subsequently filed a motion for summary judgment on the plaintiffs’ remaining claims. The court granted our motion in its entirety and, on October 5, 2023, entered final judgment in Qualcomm’s favor. The plaintiffs appealed the decision to the Ninth Circuit. On February 25, 2025, the Ninth Circuit issued a ruling dismissing all but one of the plaintiffs’ claims with prejudice and dismissing the remaining claim without prejudice.
Beginning in November 2017, several other consumer class action complaints were filed against us in Canada (in the Supreme Court of British Columbia and the Quebec Superior Court), Israel (in the Haifa District Court) and the United Kingdom (in the Competition Appeal Tribunal), each on behalf of a putative class of purchasers of cellular phones and other cellular devices, alleging violations of certain of those countries’ competition and consumer protection laws and seeking damages. The claims in these complaints are similar to those in the U.S. consumer class action complaints described above. These matters are at various stages of litigation, and we intend to continue to vigorously defend ourselves.
ParkerVision, Inc. v. QUALCOMM Incorporated: On May 1, 2014, ParkerVision filed a complaint against us in the United States District Court for the Middle District of Florida alleging that certain of our products infringed seven ParkerVision patents. On August 21, 2014, ParkerVision amended the complaint, alleging that we infringed 11 ParkerVision patents and sought damages and injunctive and other relief. ParkerVision subsequently reduced the number of patents asserted to three. The asserted patents are now expired, and injunctive relief is no longer available. ParkerVision continues to seek damages related to the sale of many of our radio frequency (RF) products sold between 2008 and 2018. On March 23, 2022, the district court entered judgment in our favor on all claims and closed the case. On April 20, 2022, ParkerVision filed a notice of appeal to the United States Court of Appeals for the Federal Circuit (Federal Circuit). On September 6, 2024, the Federal Circuit reversed the judgment of the district court, citing certain substantive and procedural issues, and remanded the case to the district court for further proceedings. We intend to continue to vigorously defend ourselves in this matter.
Arm Ltd. v. QUALCOMM Incorporated: On August 31, 2022, Arm Ltd. (Arm) filed a complaint against us in the United States District Court for the District of Delaware. Our subsidiaries Qualcomm Technologies, Inc. and NuVia, Inc. (Nuvia) are also named in the complaint. The complaint alleges that following our acquisition of Nuvia, we and Nuvia breached Nuvia’s Architecture License Agreement with Arm (the Nuvia ALA) by failing to comply with the termination obligations under the Nuvia ALA. Arm is seeking specific performance, including that we cease all use of and destroy any technology that was developed under the Nuvia ALA, including processor core technology (which Arm alleges includes our custom Qualcomm Oryon CPU cores). Arm’s complaint also contended that we violated the Lanham Act through trademark infringement and false designation of origin through unauthorized use of Arm’s trademarks and sought associated injunctive and declaratory relief; however, Arm dismissed these claims prior to trial. On September 30, 2022, we filed our Answer and Counterclaim in response to Arm’s complaint denying Arm’s claims. Our counterclaim seeks a declaratory judgment that we did not breach the Nuvia ALA or the Technology License Agreement between Nuvia and Arm, and that, following the acquisition of Nuvia, our architected cores (including all further developments, iterations or instantiations of the technology we acquired from Nuvia) and System-on-Chip (SoC) products incorporating such cores are fully licensed under our existing Architecture License Agreement with Arm (the Qualcomm ALA) and Technology License Agreement with Arm (the Qualcomm TLA). A trial was held beginning on December 16, 2024, and on December 20, 2024, the jury found that (i) Qualcomm did not breach the Nuvia ALA and (ii) Qualcomm CPUs that include designs acquired in the Nuvia acquisition are licensed under the Qualcomm ALA. The jury was unable to reach a verdict with respect to Arm’s claim as to whether Nuvia breached the Nuvia ALA. The parties have filed various post-trial motions in this matter, including motions for judgment as a matter of law. We intend to continue to vigorously defend ourselves against Arm’s claims in this matter.
On April 18, 2024, we filed a separate complaint (captioned QUALCOMM Incorporated v. Arm Ltd.) against Arm in the United States District Court for the District of Delaware. The complaint alleges that Arm has breached the Qualcomm ALA by failing to provide certain deliverables that Arm is obligated to provide. The complaint seeks an order that Arm comply with its contractual obligations, damages, and additional relief. Arm moved to dismiss this complaint, and on October 30, 2024, the court denied Arm’s motion to dismiss. On December 16, 2024, we filed a First Amended Complaint, alleging additional causes of action based on Arm improperly seeking to terminate the Qualcomm ALA and improperly publicizing that it was seeking to terminate the Qualcomm ALA. Arm has moved to dismiss the First Amended Complaint. On March 27, 2025, we moved to file a Second Amended Complaint to add a claim that Arm has breached the Qualcomm TLA by failing to provide license offers at commercially reasonable prices and terms. Trial is scheduled to begin on March 9, 2026.
On October 22, 2024, Arm provided us with a notice alleging that we have breached the Qualcomm ALA by marketing products that contain CPUs that Arm alleges use designs, technology and code created by Nuvia employees prior to our acquisition of Nuvia; by seeking support and verification from Arm for additional products that use such alleged designs, technology and code; and by suing Arm for breach of the Qualcomm ALA. Arm’s notice asserts that it will have the right to terminate the Qualcomm ALA if such alleged breaches are not cured within 60 days of such notice. We disagree with Arm’s allegations, including that we are, or have been, in breach of the Qualcomm ALA. On January 8, 2025, Arm notified us that it was withdrawing its October 22, 2024 notice of breach and indicated that it has no current plan to terminate the Qualcomm ALA, while reserving its rights pending the outcome of the ongoing litigation.
Contingent Losses and Other Considerations: Litigation and investigations are inherently uncertain, and we face difficulties in evaluating or estimating likely outcomes or ranges of possible loss, particularly in antitrust and trade regulation investigations. We have not recorded any accrual at March 30, 2025 for contingent losses associated with the pending matters described above based on our belief that losses, while reasonably possible, are not probable. Further, any possible amount or range of loss cannot be reasonably estimated at this time. The unfavorable resolution of one or more of these matters could have a material adverse effect on our business, results of operations, financial condition or cash flows. We are engaged in numerous other legal actions not described above (for example, our 2010 European Commission matter relating to the Icera complaint, and other matters arising in the ordinary course of our business, including those relating to employment matters or the initiation or defense of proceedings relating to intellectual property rights) and, while there can be no assurance, we believe that the ultimate outcome of these other legal actions will not have a material adverse effect on our business, results of operations, financial condition or cash flows.
v3.25.1
Segment Information
6 Months Ended
Mar. 30, 2025
Segment Reporting [Abstract]  
Segment Information
Note 6. Segment Information
We are organized on the basis of products and services and have three reportable segments. We conduct business primarily through our QCT semiconductor business and our QTL licensing business. QCT develops and supplies integrated circuits and system software with advanced connectivity and high-performance, low-power computing technologies for use in mobile devices; automotive systems for connectivity, digital cockpit and ADAS/AD; and IoT including consumer electronic devices, industrial devices and edge networking products. QTL grants licenses or otherwise provides rights to use portions of our intellectual property portfolio, which includes certain patent rights essential to and/or useful in the manufacture and sale of certain wireless products. Our QSI (Qualcomm Strategic Initiatives) reportable segment makes strategic investments. We also have nonreportable segments, including QGOV (Qualcomm Government Technologies) and our cloud computing processing initiative.
The table below presents revenues and earnings (loss) before income taxes (EBT) for reportable segments (in millions):
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Revenues
QCT$9,469 $8,026 $19,553 $16,449 
QTL1,319 1,318 2,854 2,778 
QSI— — 16 
Reconciling items191 42 242 82 
Total$10,979 $9,389 $22,649 $19,325 
EBT
QCT$2,857 $2,288 $6,103 $4,881 
QTL929 933 2,086 2,013 
QSI10 96 29 107 
Reconciling items(691)(819)(1,478)(1,541)
Total$3,105 $2,498 $6,740 $5,460 
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Revenues
Nonreportable segments$48 $42 $99 $82 
Unallocated revenues
143 — 143 — 
$191 $42 $242 $82 
EBT
Unallocated revenues
$143 $— $143 $— 
Unallocated cost of revenues(60)(57)(119)(113)
Unallocated research and development expenses(558)(584)(1,156)(1,116)
Unallocated selling, general and administrative expenses(184)(229)(372)(414)
Unallocated other income
— — — 28 
Unallocated interest expense(163)(172)(326)(350)
Unallocated investment and other income, net138 228 358 434 
Nonreportable segments(7)(5)(6)(10)
$(691)$(819)$(1,478)$(1,541)
Certain revenues were not allocated to our segments in our management reports because they were not considered in evaluating segment results. Unallocated revenues in the second quarter and first six months of fiscal 2025 were comprised of licensing revenues resulting from a recent settlement of a licensing dispute.
v3.25.1
Fair Value Measurements and Marketable Securities
6 Months Ended
Mar. 30, 2025
Fair Value Measurements [Abstract]  
Fair Value Measurements and Marketable Securities
Note 7. Fair Value Measurements and Marketable Securities
The following table presents our fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at March 30, 2025 (in millions):
Level 1Level 2Level 3Total
Assets    
Cash equivalents$2,720 $241 $— $2,961 
Marketable securities:    
Corporate bonds and notes— 5,048 — 5,048 
Mortgage- and asset-backed securities— 1,037 — 1,037 
U.S. Treasury securities and government-related securities303 183 — 486 
Equity securities72 — — 72 
Total marketable securities375 6,268 — 6,643 
Derivative instruments— 23 — 23 
Other investments (1)
963 — 56 1,019 
Total assets measured at fair value$4,058 $6,532 $56 $10,646 
Liabilities    
Derivative instruments$— $176 $— $176 
Other liabilities (1)
959 — — 959 
Total liabilities measured at fair value$959 $176 $— $1,135 
(1) Other investments and other liabilities included in Level 1 are comprised of our deferred compensation plan assets and liabilities.
Long-term Debt. At March 30, 2025, the aggregate fair value of our outstanding fixed-rate notes, based on Level 2 inputs, was approximately $13.8 billion.
Marketable Securities. At March 30, 2025 and September 29, 2024, our marketable securities were all classified as current and were primarily comprised of available-for-sale debt securities (the vast majority of which were corporate bonds and notes).
The contractual maturities of available-for-sale debt securities were as follows (in millions):
March 30,
2025
Years to Maturity
Less than one year$1,451 
One to five years4,083 
No single maturity date1,037 
Total$6,571 
Debt securities with no single maturity date included mortgage- and asset-backed securities.
v3.25.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 30, 2025
Mar. 24, 2024
Mar. 30, 2025
Mar. 24, 2024
Pay vs Performance Disclosure        
Net income $ 2,812 $ 2,326 $ 5,992 $ 5,093
v3.25.1
Insider Trading Arrangements
3 Months Ended
Mar. 30, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
v3.25.1
Basis of Presentation and Significant Accounting Policies Update (Policies)
6 Months Ended
Mar. 30, 2025
Basis of Presentation [Abstract]  
Fiscal Period, Policy
We operate and report using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three and six months ended March 30, 2025 and March 24, 2024 included 13 weeks and 26 weeks, respectively. Our fiscal year for 2025 will include 52 weeks.
Use of Estimates, Policy The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.
Recent Accounting Pronouncements, Policy
Segment Reporting Disclosures: In November 2023, the Financial Accounting Standards Board (FASB) issued new requirements to disclose certain incremental segment information on an annual and interim basis, including (among other items) additional disclosure about significant segment expenses. We will adopt the new requirements for our annual periods starting in fiscal 2025 (and interim periods thereafter) on a retrospective basis.
Income Tax Disclosures: In December 2023, the FASB issued new requirements to disclose annually certain additional detailed income tax information related to the effective tax rate reconciliation and income taxes paid, among other items. We will adopt the new requirements starting in fiscal 2026 on a retrospective basis.
Income Statement - Expense Disaggregation Disclosures: In November 2024, the FASB issued new requirements to disclose certain additional expense information on an annual and interim basis, including (among other items) the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization included within each income statement expense caption, as applicable. We will adopt the new requirements for our annual periods starting in fiscal 2028 (and interim periods thereafter) on a prospective basis.
Revenue Recognition, Policy We disaggregate our revenues by segment (Note 6), by products and services (as presented on our condensed consolidated statements of operations), and for our QCT (Qualcomm CDMA Technologies) segment, by revenue stream, which is based on the industry and application in which our products are sold (as presented below). In certain cases, the determination of QCT revenues by industry and application requires the use of certain assumptions. Substantially all of QCT’s revenues consist of equipment revenues that are recognized at a point in time, and substantially all of QTL’s (Qualcomm Technology Licensing) revenues represent licensing revenues that are recognized over time and are principally from royalties generated through our licensees’ sales of mobile handsets.
Earnings Per Common Share, Policy Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share is computed by dividing net income by the combination of the weighted-average number of common shares outstanding and the weighted-average number of dilutive common share equivalents, comprised of shares issuable under our share-based compensation plans, during the reporting period, using the treasury stock method.
Segment Reporting, Policy We are organized on the basis of products and services and have three reportable segments.
v3.25.1
Composition of Certain Financial Statement Items (Tables)
6 Months Ended
Mar. 30, 2025
Condensed Financial Information Disclosure [Abstract]  
Inventories
Inventories (in millions)
March 30,
2025
September 29,
2024
Raw materials$298 $340 
Work-in-process3,750 3,497 
Finished goods2,148 2,586 
$6,196 $6,423 
QCT Revenues Disaggregated
QCT revenue streams were as follows (in millions):
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Handsets (1)$6,929 $6,180 $14,503 $12,867 
Automotive (2)959 603 1,920 1,201 
IoT (internet of things) (3)
1,581 1,243 3,130 2,381 
Total QCT revenues$9,469 $8,026 $19,553 $16,449 
(1) Includes revenues from products sold for use in mobile handsets.
(2) Includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and advanced driver assistance systems (ADAS) and automated driving (AD).
(3) Primarily includes products sold for use in the following industries and applications: consumer (including personal computers (PCs), tablets, voice and music and extended reality (XR)), edge networking (including mobile broadband and wireless access points) and industrial (including handhelds, retail, tracking and logistics and utilities).
Revenue recognized from performance obligations satisfied in previous periods
Revenues recognized from performance obligations satisfied (or partially satisfied) in previous periods generally include certain sales-based royalty revenues related to system software, certain amounts related to customer incentives and licensing revenues recognized related to devices sold in prior periods (including revenues resulting from certain settlements and adjustments to prior period royalty estimates, which include the impact of the reporting by our licensees of actual royalties due) and were as follows (in millions):
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Revenues recognized from previously satisfied performance obligations$285 $55 $526 $206 
Customer Concentrations - Revenues Revenues from each customer/licensee that were 10% or greater of total revenues were as follows:
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Customer/licensee (x)
27 %24 %21 %21 %
Customer/licensee (y)
18 19 21 22 
Customer/licensee (z)10 14 12 14 
Investment and Other Income (Expense), Net
Investment and Other Income, Net (in millions)
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Interest and dividend income$167 $160 $336 $312 
Net gains (losses) on marketable securities
18 (3)37 
Net (losses) gains on other investments
(5)155 26 159 
Net (losses) gains on deferred compensation plan assets
(34)62 (20)126 
Impairment losses on other investments(16)(50)(41)(62)
Other18 53 (1)
$148 $330 $391 $542 
v3.25.1
Capital Stock Earnings per Common Share (Tables)
6 Months Ended
Mar. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Capital Units
Shares Outstanding. Shares of common stock outstanding at March 30, 2025 were as follows (in millions):
Balance at September 29, 2024
1,113 
Issued
Repurchased(22)
Balance at March 30, 2025
1,100 
Schedule of Earnings Per Share, Basic and Diluted The following table provides information about the diluted earnings per share calculation (in millions):
 Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Dilutive common share equivalents included in diluted shares10 13 11 12 
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period— 
v3.25.1
Segment Information (Tables)
6 Months Ended
Mar. 30, 2025
Segment Reporting [Abstract]  
Revenues and EBT for reportable segments
The table below presents revenues and earnings (loss) before income taxes (EBT) for reportable segments (in millions):
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Revenues
QCT$9,469 $8,026 $19,553 $16,449 
QTL1,319 1,318 2,854 2,778 
QSI— — 16 
Reconciling items191 42 242 82 
Total$10,979 $9,389 $22,649 $19,325 
EBT
QCT$2,857 $2,288 $6,103 $4,881 
QTL929 933 2,086 2,013 
QSI10 96 29 107 
Reconciling items(691)(819)(1,478)(1,541)
Total$3,105 $2,498 $6,740 $5,460 
Reconciling items for reportable segments - revenues
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Revenues
Nonreportable segments$48 $42 $99 $82 
Unallocated revenues
143 — 143 — 
$191 $42 $242 $82 
EBT
Unallocated revenues
$143 $— $143 $— 
Unallocated cost of revenues(60)(57)(119)(113)
Unallocated research and development expenses(558)(584)(1,156)(1,116)
Unallocated selling, general and administrative expenses(184)(229)(372)(414)
Unallocated other income
— — — 28 
Unallocated interest expense(163)(172)(326)(350)
Unallocated investment and other income, net138 228 358 434 
Nonreportable segments(7)(5)(6)(10)
$(691)$(819)$(1,478)$(1,541)
Reconciling items for reportable segments - EBT
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months EndedSix Months Ended
March 30,
2025
March 24,
2024
March 30,
2025
March 24,
2024
Revenues
Nonreportable segments$48 $42 $99 $82 
Unallocated revenues
143 — 143 — 
$191 $42 $242 $82 
EBT
Unallocated revenues
$143 $— $143 $— 
Unallocated cost of revenues(60)(57)(119)(113)
Unallocated research and development expenses(558)(584)(1,156)(1,116)
Unallocated selling, general and administrative expenses(184)(229)(372)(414)
Unallocated other income
— — — 28 
Unallocated interest expense(163)(172)(326)(350)
Unallocated investment and other income, net138 228 358 434 
Nonreportable segments(7)(5)(6)(10)
$(691)$(819)$(1,478)$(1,541)
v3.25.1
Fair Value Measurements (Tables)
6 Months Ended
Mar. 30, 2025
Fair Value Measurements [Abstract]  
Fair value hierarchy for assets and liabilities measured at fair value on a recurring basis
The following table presents our fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at March 30, 2025 (in millions):
Level 1Level 2Level 3Total
Assets    
Cash equivalents$2,720 $241 $— $2,961 
Marketable securities:    
Corporate bonds and notes— 5,048 — 5,048 
Mortgage- and asset-backed securities— 1,037 — 1,037 
U.S. Treasury securities and government-related securities303 183 — 486 
Equity securities72 — — 72 
Total marketable securities375 6,268 — 6,643 
Derivative instruments— 23 — 23 
Other investments (1)
963 — 56 1,019 
Total assets measured at fair value$4,058 $6,532 $56 $10,646 
Liabilities    
Derivative instruments$— $176 $— $176 
Other liabilities (1)
959 — — 959 
Total liabilities measured at fair value$959 $176 $— $1,135 
(1) Other investments and other liabilities included in Level 1 are comprised of our deferred compensation plan assets and liabilities.
Investments Classified by Contractual Maturity Date
The contractual maturities of available-for-sale debt securities were as follows (in millions):
March 30,
2025
Years to Maturity
Less than one year$1,451 
One to five years4,083 
No single maturity date1,037 
Total$6,571 
v3.25.1
Composition of Certain Financial Statement Items Inventories (Details) - USD ($)
$ in Millions
Mar. 30, 2025
Sep. 29, 2024
Inventory, Net [Abstract]    
Raw materials $ 298 $ 340
Work-in-process 3,750 3,497
Finished goods 2,148 2,586
Inventories $ 6,196 $ 6,423
v3.25.1
Composition of Certain Financial Statement Items Other Assets (Details) - USD ($)
$ in Millions
Mar. 30, 2025
Sep. 29, 2024
Long-Term Purchase Commitment [Line Items]    
Advance payment related to multi-year capacity commitments $ 2,700 $ 3,000
Other Current Assets    
Long-Term Purchase Commitment [Line Items]    
Advance payment related to multi-year capacity commitments 1,600 765
Other Assets    
Long-Term Purchase Commitment [Line Items]    
Advance payment related to multi-year capacity commitments $ 1,100 $ 2,200
v3.25.1
Composition of Certain Financial Statement Items Revenues (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 30, 2025
Mar. 24, 2024
Mar. 30, 2025
Mar. 24, 2024
Revenue        
Revenues $ 10,979 $ 9,389 $ 22,649 $ 19,325
Revenues recognized from previously satisfied performance obligations $ 285 55 $ 526 206
Minimum        
Revenue        
Patent license agreement expiration period 2027   2027  
Maximum        
Revenue        
Patent license agreement expiration period 2031   2031  
QCT        
Revenue        
Revenues $ 9,469 8,026 $ 19,553 16,449
Handsets | QCT        
Revenue        
Revenues [1] 6,929 6,180 14,503 12,867
Automotive | QCT        
Revenue        
Revenues [2] 959 603 1,920 1,201
IoT | QCT        
Revenue        
Revenues [3] $ 1,581 $ 1,243 $ 3,130 $ 2,381
[1] Includes revenues from products sold for use in mobile handsets.
[2] Includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and advanced driver assistance systems (ADAS) and automated driving (AD).
[3] Primarily includes products sold for use in the following industries and applications: consumer (including personal computers (PCs), tablets, voice and music and extended reality (XR)), edge networking (including mobile broadband and wireless access points) and industrial (including handhelds, retail, tracking and logistics and utilities).
v3.25.1
Composition of Certain Financial Statement Items Concentrations (Details) - Sales - Customer Concentration Risk
3 Months Ended 6 Months Ended
Mar. 30, 2025
Mar. 24, 2024
Mar. 30, 2025
Mar. 24, 2024
Customer/licensee (x)        
Concentration Risk        
Concentration Risk, Percentage 27.00% 24.00% 21.00% 21.00%
Customer/licensee (y)        
Concentration Risk        
Concentration Risk, Percentage 18.00% 19.00% 21.00% 22.00%
Customer/licensee (z)        
Concentration Risk        
Concentration Risk, Percentage 10.00% 14.00% 12.00% 14.00%
v3.25.1
Composition of Certain Financial Statement Items Investment and Other Income (Expense), Net (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 30, 2025
Mar. 24, 2024
Mar. 30, 2025
Mar. 24, 2024
Investment Income, Net [Abstract]        
Interest and dividend income $ 167 $ 160 $ 336 $ 312
Net gains (losses) on marketable securities 18 (3) 37 8
Net (losses) gains on other investments (5) 155 26 159
Net (losses) gains on deferred compensation plan assets (34) 62 (20) 126
Impairment losses on other investments (16) (50) (41) (62)
Other 18 6 53 (1)
Investment and other income, net $ 148 $ 330 $ 391 $ 542
v3.25.1
Composition of Certain Financial Statement Items Discontinued Operations (Details)
$ in Billions
Jun. 01, 2023
USD ($)
Veoneer's Active Safety  
Discontinued Operations [Abstract]  
Disposal Group, Including Discontinued Operation, Consideration $ 1.5
v3.25.1
Income Taxes (Details)
3 Months Ended 12 Months Ended
Mar. 30, 2025
Sep. 28, 2025
Income Taxes    
Effective income tax rate (benefit) 9.00%  
Forecast    
Income Taxes    
Effective income tax rate (benefit)   11.00%
Forecast | FDII Effective Tax Rate    
Income Taxes    
Effective income tax rate (benefit)   13.00%
v3.25.1
Capital Stock Share Repurchase Program (Details) - USD ($)
$ in Billions
Mar. 30, 2025
Nov. 06, 2024
Oct. 12, 2021
$10B stock repurchase program announced October 12, 2021      
Stock Repurchase Program      
Authorized amount     $ 10.0
$15B stock repurchase program announced November 6, 2024      
Stock Repurchase Program      
Authorized amount   $ 15.0  
Remaining authorized amount $ 12.5    
v3.25.1
Capital Stock Shares Outstanding (Details)
shares in Millions
6 Months Ended
Mar. 30, 2025
shares
Shares Outstanding [Abstract]  
Balance at September 29, 2024 1,113
Issued 9
Repurchased (22)
Balance at March 30, 2025 1,100
v3.25.1
Capital Stock Dividends (Details) - $ / shares
3 Months Ended 6 Months Ended
Jun. 26, 2025
Jun. 05, 2025
Apr. 18, 2025
Mar. 18, 2025
Mar. 30, 2025
Mar. 24, 2024
Mar. 30, 2025
Mar. 24, 2024
Capital Stock Dividends                
Dividends per share announced         $ 0.85 $ 0.80 $ 1.70 $ 1.60
Amount Of Increased Common Stock Dividends Per Share Announced       $ 0.89        
Subsequent Event | O2025Q3Dividend                
Capital Stock Dividends                
Dividends per share announced     $ 0.89          
Dividends Payable, Date Declared     Apr. 18, 2025          
Dividends Payable, Date to be Paid Jun. 26, 2025              
Dividends Payable, Date of Record   Jun. 05, 2025            
v3.25.1
Capital Stock Earnings per Common Share (Details) - shares
shares in Millions
3 Months Ended 6 Months Ended
Mar. 30, 2025
Mar. 24, 2024
Mar. 30, 2025
Mar. 24, 2024
Earnings Per Share [Abstract]        
Dilutive common share equivalents included in diluted shares 10 13 11 12
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period 1 0 1 7
v3.25.1
Commitments and Contingencies Legal and Regulatory Proceedings (Details)
$ in Millions
Mar. 30, 2025
USD ($)
Loss Contingencies [Line Items]  
Loss Contingency, Estimate of Possible Loss $ 0
v3.25.1
Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 30, 2025
Mar. 24, 2024
Mar. 30, 2025
Mar. 24, 2024
Segment Reporting Information [Line Items]        
Revenues $ 10,979 $ 9,389 $ 22,649 $ 19,325
Cost of revenues (4,937) (4,106) (10,098) (8,418)
Research and development expenses (2,216) (2,236) (4,446) (4,332)
Selling, general and administrative expenses (706) (707) (1,430) (1,335)
Other Operating Income (Expense), Net 0 0 0 28
Interest expense (163) (172) (326) (350)
EBT 3,105 2,498 6,740 5,460
Reconciling Items        
Segment Reporting Information [Line Items]        
Revenues 191 42 242 82
Cost of revenues (60) (57) (119) (113)
Research and development expenses (558) (584) (1,156) (1,116)
Selling, general and administrative expenses (184) (229) (372) (414)
Other Operating Income (Expense), Net 0 0 0 28
Interest expense (163) (172) (326) (350)
Investment and other (expense) income, net 138 228 358 434
EBT (691) (819) (1,478) (1,541)
Reconciling Items | Licensing Agreements        
Segment Reporting Information [Line Items]        
Revenues 143 0 143 0
QCT        
Segment Reporting Information [Line Items]        
Revenues 9,469 8,026 19,553 16,449
EBT 2,857 2,288 6,103 4,881
QTL        
Segment Reporting Information [Line Items]        
Revenues 1,319 1,318 2,854 2,778
EBT 929 933 2,086 2,013
QSI        
Segment Reporting Information [Line Items]        
Revenues 0 3 0 16
EBT 10 96 29 107
Other Operating Segment        
Segment Reporting Information [Line Items]        
Revenues 48 42 99 82
Other Operating Segment | Reconciling Items        
Segment Reporting Information [Line Items]        
EBT $ (7) $ (5) $ (6) $ (10)
v3.25.1
Fair Value Measurements Fair Value Hierarchy (Details) - Fair Value, Recurring
$ in Millions
Mar. 30, 2025
USD ($)
Assets  
Cash equivalents $ 2,961
Marketable securities 6,643
Derivative instruments 23
Other investments (1) 1,019 [1]
Total assets measured at fair value 10,646
Liabilities  
Derivative instruments 176
Other liabilities (1) 959 [1]
Total liabilities measured at fair value 1,135
Level 1  
Assets  
Cash equivalents 2,720
Marketable securities 375
Derivative instruments 0
Other investments (1) 963 [1]
Total assets measured at fair value 4,058
Liabilities  
Derivative instruments 0
Other liabilities (1) 959 [1]
Total liabilities measured at fair value 959
Level 2  
Assets  
Cash equivalents 241
Marketable securities 6,268
Derivative instruments 23
Other investments (1) 0 [1]
Total assets measured at fair value 6,532
Liabilities  
Derivative instruments 176
Other liabilities (1) 0 [1]
Total liabilities measured at fair value 176
Level 3  
Assets  
Cash equivalents 0
Marketable securities 0
Derivative instruments 0
Other investments (1) 56 [1]
Total assets measured at fair value 56
Liabilities  
Derivative instruments 0
Other liabilities (1) 0 [1]
Total liabilities measured at fair value 0
Corporate bonds and notes  
Assets  
Marketable securities 5,048
Corporate bonds and notes | Level 1  
Assets  
Marketable securities 0
Corporate bonds and notes | Level 2  
Assets  
Marketable securities 5,048
Corporate bonds and notes | Level 3  
Assets  
Marketable securities 0
U.S. Treasury and government-related Securities  
Assets  
Marketable securities 486
U.S. Treasury and government-related Securities | Level 1  
Assets  
Marketable securities 303
U.S. Treasury and government-related Securities | Level 2  
Assets  
Marketable securities 183
U.S. Treasury and government-related Securities | Level 3  
Assets  
Marketable securities 0
Mortgage- and asset-backed securities  
Assets  
Marketable securities 1,037
Mortgage- and asset-backed securities | Level 1  
Assets  
Marketable securities 0
Mortgage- and asset-backed securities | Level 2  
Assets  
Marketable securities 1,037
Mortgage- and asset-backed securities | Level 3  
Assets  
Marketable securities 0
Equity securities  
Assets  
Marketable securities 72
Equity securities | Level 1  
Assets  
Marketable securities 72
Equity securities | Level 2  
Assets  
Marketable securities 0
Equity securities | Level 3  
Assets  
Marketable securities $ 0
[1] Other investments and other liabilities included in Level 1 are comprised of our deferred compensation plan assets and liabilities.
v3.25.1
Fair Value Measurements Long-term Debt (Details)
$ in Billions
Mar. 30, 2025
USD ($)
Level 2  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Long-term Debt, Fair Value $ 13.8
v3.25.1
Marketable Securities (Details) - Available-for-Sale Securities [Member]
$ in Millions
Mar. 30, 2025
USD ($)
Marketable Securities  
Less than one year $ 1,451
One to five years 4,083
No single maturity date 1,037
Debt Securities, Available-for-sale $ 6,571